文献速递泌尿生殖介入CTMRUSDSA

经动脉栓塞作为经皮射频消融的辅助手段治疗肾脏肿瘤:文献综述、现有栓塞材料概览及先进影像引导肿瘤消融的前景

Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation.
PubMed 文献 · Eur J Radiol · 2016-11-02

本文系统综述了经动脉栓塞(TAE)作为经皮射频消融(RFA)辅助手段治疗肾脏肿瘤的文献,分析了技术、肿瘤与患者特征以及技术、临床和肿瘤学结局,并概述了现有栓塞材料及先进影像引导肿瘤消融的前景。结论认为,TAE辅助经皮RFA对于困难部位的T1a期肿瘤和T1b期肿瘤可行、非常有效且安全。

要点

  • TAE作为经皮RFA的辅助手段,对困难部位T1a期和T1b期肾肿瘤可行、非常有效且安全。
  • 非对照单中心试验中治疗失败率存在差异,操作者经验和消融技术可能解释部分不同结局。
  • 对照试验的主要局限性是缺乏充分的随机化。

核心结论

  • TAE作为经皮RFA的辅助手段,对于困难部位的T1a期肿瘤和T1b期肿瘤可行、非常有效且安全。

研究设计与样本

  • 系统综述文献,分析TAE辅助经皮RFA治疗肾肿瘤的技术、肿瘤与患者特征及技术、临床和肿瘤学结局。
  • 综述还概述了现有栓塞材料及先进影像引导肿瘤消融的影像学前景。

临床应用与阅片要点

  • 作者认为,对于困难部位的T1a期肿瘤和T1b期肿瘤,TAE作为经皮RFA的辅助手段可行、非常有效且安全。
  • 作者指出,临床实施对于将影像引导肿瘤消融作为高度标准化的有效操作非常重要,即使在最具挑战性的局限性肾肿瘤病例中也是如此。

局限性

  • 非对照单中心试验中治疗失败率存在差异。
  • 对照试验的主要局限性是缺乏充分的随机化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Percutaneous radiofrequency ablation (RFA) for the treatment of stage I renal cell carcinoma has recently gained significant attention as the now available long-term and controlled data demonstrate that RFA can result in disease-free and cancer-specific survival comparable with partial and/or radical nephrectomy. In the non-controlled single center trials, however, the rates of treatment failure vary. Operator experience and ablation technique may explain some of the different outcomes. In the controlled trials, a major limitation is the lack of adequate randomization. In case reports, original series and overview articles, transarterial embolization (TAE) before percutaneous RFA was promising to increase tumor control and to reduce complications. The purpose of this study was to systematically review the literature on TAE as add-on to percutaneous RFA for renal tumors. Specific data regarding technique, tumor and patient characteristics as well as technical, clinical and oncologic outcomes have been analyzed. Additionally, an overview of state-of-the-art embolization materials and the radiological perspective of advanced image-guided tumor ablation (TA) will be discussed. In conclusion, TAE as add-on to percutaneous RFA is feasible and very effective and safe for the treatment of T1a tumors in difficult locations and T1b tumors. Advanced radiological techniques and technologies such as microwave ablation, innovative embolization materials and software-based solutions are now available, or will be available in the near future, to reduce the limitations of bland RFA. Clinical implementation is extremely important for performing image-guided TA as a highly standardized effective procedure even in the most challenging cases of localized renal tumors.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Sommer CM, Pallwein-Prettner L, Vollherbst DF, et al. Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation. Eur J Radiol. 2016. PMID: 28027741. doi:10.1016/j.ejrad.2016.10.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。